FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on August 12, 2020 include:
Coronavirus (COVID-19) updates:
- August 18, 2020: Daily Roundup: FDA provides supporting information on respirators for healthcare providers and manufacturers amid the COVID-19 pandemic
- August 18, 2020: From the Health Affairs Blog, FDA leadership on:
- The FDA Response To COVID-19 At Six Months: Regulatory Innovation In The Face Of A Pandemic
- FDA Initiatives To Accelerate The Development Of COVID-19 Therapeutics
- FDA Support For Expedited Access To COVID-19 Diagnostics
- Ensuring The Safety And Effectiveness Of A COVID-19 Vaccine
- August 18, 2020: FDA Insight podcast: Health Fraud and COVID-19 + listen to more episodes
- August 15, 2020: FDA Issues Emergency Use Authorization to Yale University for Saliva Direct, a New Method of Sample Processing
- August 12, 2020: Help Stop the Spread of Coronavirus and Protect Your Family
.png)
No hay comentarios:
Publicar un comentario